Skip to main content
Skip to FDA Search
Skip to in this section menu
Skip to footer links

An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search FDA

Featured

Report a Product Problem
Contact FDA
FDA Guidance Documents
Recalls, Market Withdrawals and Safety Alerts
Press Announcements
Warning Letters
Advisory Committees
En Español

Products

Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood, and Biologics
Animal and Veterinary
Cosmetics
Tobacco Products

Topics

About FDA
Combination Products
Regulatory Information
Safety
Emergency Preparedness
International Programs
News and Events
Training and Continuing Education
Inspections and Compliance
Science and Research

Information For

Consumers
Patients
Industry
Health Professionals
Federal, State and Local Officials

Home
Drugs
Drug Safety and Availability
Information by Drug Class

Drug Safety and Availability

In this section

Information by Drug Class

Information by Drug Class

Information by Drug Class

The following pages contain safety, regulatory and availability information.

What's New

Endothelin Receptor Antagonist REMS Information
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

Content current as of:

07/03/2025
Regulated Product(s)
- Drugs

FDA Archive
About FDA
Accessibility

Visitor Information
Website Policies / Privacy
No FEAR Act
Vulnerability Disclosure Policy

FOIA
HHS.gov
USA.gov

Contact FDA Follow FDA on Facebook Follow FDA on X Follow FDA on Instagram
Follow FDA on LinkedIn View FDA videos on YouTube Subscribe to FDA RSS feeds

Contact Number 1-888-INFO-FDA (1-888-463-6332)

Back to Top